We analyse and differentiate endogenous or therapeutic peptides and interfering products in (pre-)clinical study samples.
Selective and sensitive analysis of peptide hormones in clinical studies is challenging. Endogenous therapeutic peptides with a similar molecular structure, biological precursors, or inactive degradation products can interfere with the analytical method. This can lead to biased results and an erroneous biological interpretation of the study outcome. We provide an analytical solution for this challenge.
Get in touch with us
